NL-OMON31048尚未招募不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma; a feasibility study in patients who do not show response on bevacizumab therapy. - Radiolabeled bevacizumab in resistant patients with colon carcinoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Metastatic colon cancer.
- •2. Progression of disease (RECIST) after chemotherapy including bevacizumab
- •3. At least 18 years of age.
- •4. A life expectancy of at least 3 months.
- •5. Adequate hematologic, hepatic, and renal function.
- •6. Signed written informed consent.
- •7. Able to comply with the protocol.
排除标准
- •1.Radiotherapy within 14 days before the start of the study of the involved area.
- •2.Major surgery within 28 days before the initiation of the study.
- •3.Clinically significant cardiovascular disease.
- •4.Pregnant or lactating women. Documentation of a negative pregnancy test must be available for pre-menopausal women with intact reproductive organs and for women less than two years after menopause.
- •5.CNS metastases (CT-scan not mandatory).
- •6.Treatment with any investigational drug within 30 days before the start of the study.
- •7.Prior allergic reaction to immunoglobulins or immunoglobulin allergy.
研究者
相似试验
已完成
不适用
Molecular imaging with radiolabeled bevacizumab in metastatic colon carcinoma. A feasibility study in patients who do show response on bevacizumab therapy10017990colon cancerNL-OMON30912niversitair Medisch Centrum Groningen6
招募中
不适用
Targeted fluorescence imaging using bevacizumab-800CW within Age-related Macular Degeneration (AMD) patients to evaluate the upregulation of VEGFage related macula degeneration10047060NL-OMON52066niversitair Medisch Centrum Groningen24
已完成
不适用
Everolimage. 89Zr-bevacizumab PET imaging in patients with Renal Cell Carcinoma treated with everolimus; a pilot study.kidney cancer1003836310038430renal cell carcinomaNL-OMON36512niversitair Medisch Centrum Groningen14
已完成
不适用
89Zr-bevacizumab labelled PET imaging in patients with Renal Cell Carcinoma treated with sunitinib or bevacizumab plus interferon; a pilot studyNL-OMON33835niversitair Medisch Centrum Groningen26
尚未招募
不适用
Radiolabeled bevacizumab as a tracer of VEGF expression in patients with colorectal liver metastasescolorectal liver metastases10027476NL-OMON29757niversitair Medisch Centrum Sint Radboud10